Cargando…
Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Autores principales: | Ranjbar, Keivan, Moghadami, Mohsen, Mirahmadizadeh, Alireza, Fallahi, Mohammad Javad, Khaloo, Vahid, Shahriarirad, Reza, Erfani, Amirhossein, Khodamoradi, Zohre, Saadi, Mohammad Hasan Gholampoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111051/ https://www.ncbi.nlm.nih.gov/pubmed/33975548 http://dx.doi.org/10.1186/s12879-021-06130-7 |
Ejemplares similares
-
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
por: Ranjbar, Keivan, et al.
Publicado: (2021) -
Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran
por: Shahriarirad, Reza, et al.
Publicado: (2020) -
The mental health impact of COVID-19 outbreak: a Nationwide Survey in Iran
por: Shahriarirad, Reza, et al.
Publicado: (2021) -
Evaluation of students' attitude and emotions towards the sudden closure of schools during the COVID-19 pandemic: a cross-sectional study
por: Mirahmadizadeh, Alireza, et al.
Publicado: (2020) -
Primary malignant epithelioid hemangioendothelioma of the pleura: A review and report of a novel case
por: Rezvani, Alireza, et al.
Publicado: (2022)